Data-Zyme CK Calorimetric/UV Procedure
by Data Medical Associates, Inc. 510(k)
Active
510(k) K790343
Overview
The Data-Zyme CK Calorimetric/UV Procedure is a clinical chemistry device used for the differential rate kinetic method of measuring creatine phosphokinase or isoenzymes. It functions as a diagnostic tool to assist in the analysis of enzyme activity levels within clinical laboratory settings.
This device is supplied as part of a traditional 510(k) premarket notification process and has received FDA 510(k) clearance under K790343. It is regulated under the clinical chemistry medical specialty and is classified as a class 2 medical device.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK790343 | Date1 May 1979 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 6 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- JHS
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1215
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Other devices from Data Medical Associates, Inc.
Questions
What is the primary function of the Data-Zyme CK Calorimetric/UV Procedure?
This device is a clinical chemistry tool used to measure creatine phosphokinase or its isoenzymes. It utilizes a differential rate kinetic method to assist laboratory professionals in analyzing enzyme activity levels.
How is this device regulated?
The Data-Zyme CK Calorimetric/UV Procedure is classified as a class 2 medical device under the clinical chemistry medical specialty. It has received FDA 510(k) clearance under K790343, confirming it was processed through a traditional premarket notification.
What is the regulatory classification of this device?
The device is regulated under 21 CFR 862.1215 and is assigned the product code JHS. It was determined to be substantially equivalent to existing devices during its 1979 review process.